These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 1931447)
1. Alkylating agents. Connors TA Cancer Chemother Biol Response Modif; 1991; 12():27-42. PubMed ID: 1931447 [No Abstract] [Full Text] [Related]
2. Alkylating agents. Connors TA Cancer Chemother Biol Response Modif; 1992; 13():31-44. PubMed ID: 1389913 [No Abstract] [Full Text] [Related]
3. Alkylating agents. Connors TA Cancer Chemother Biol Response Modif; 1990; 11():29-44. PubMed ID: 2223396 [No Abstract] [Full Text] [Related]
4. Alkylating agents, nitrosoureas and alkyltriazenes. Connors TA Cancer Chemother Biol Response Modif; 1988; 10():23-32. PubMed ID: 3079385 [No Abstract] [Full Text] [Related]
5. [Use of cytostatic drugs in therapy and research]. Wie H Tidsskr Nor Laegeforen; 1973 Mar; 93(7):443-9. PubMed ID: 4699142 [No Abstract] [Full Text] [Related]
6. [Chemotherapy of solid tumors. Epitheliomas and sarcomas of non-hematopoietic organs]. Clavel B Sem Hop; 1971 May; 47(22):1439-48. PubMed ID: 4326096 [No Abstract] [Full Text] [Related]
8. Biochemical aspects of drug combinations. Brockman RW Cancer Chemother Rep 2; 1974 Mar; 4(1):115-29. PubMed ID: 4135108 [No Abstract] [Full Text] [Related]
9. An outline of cancer chemotherapy. Connors TA Rev Roum Inframicrobiol; 1971; 8(3):135-51. PubMed ID: 5152643 [No Abstract] [Full Text] [Related]
10. Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies. Hall AG; Tilby MJ Blood Rev; 1992 Sep; 6(3):163-73. PubMed ID: 1422285 [TBL] [Abstract][Full Text] [Related]
11. [Anticancer chemotherapy. Prescription in the presence of renal insufficiency]. Moulin B; Fillastre JP; Godin M; Chantrel F Nephrologie; 1995; 16(3):233-8. PubMed ID: 7783831 [No Abstract] [Full Text] [Related]
12. Cancer chemotherapy. Med Lett Drugs Ther; 1983 Jan; 25(626):1-8. PubMed ID: 6848903 [No Abstract] [Full Text] [Related]
13. Some developments in cancer chemotherapy. Neidle S Nurs Mirror; 1978 Mar; 146(12):18-20. PubMed ID: 246548 [No Abstract] [Full Text] [Related]
14. [The principal anticancer agents]. Marty M; Gisselbrecht C; Mignot L; Unger P; Boiron M Rev Prat; 1981 Oct; 31(43):2979-80 passim. PubMed ID: 7291906 [No Abstract] [Full Text] [Related]
15. [Selectivity of the antitumor action of 2 alkylating compounds with different carrier structures]. Astardzhieva Z; Stoichkov I Eksp Med Morfol; 1988; 27(2):14-7. PubMed ID: 3168903 [No Abstract] [Full Text] [Related]
16. [Current aspects of the chemotherapy of cancer]. Vicente J Cah Med; 1971 Feb; 12(3):209-24. PubMed ID: 4930637 [No Abstract] [Full Text] [Related]
17. DNA and its associated processes as targets for cancer therapy. Hurley LH Nat Rev Cancer; 2002 Mar; 2(3):188-200. PubMed ID: 11990855 [TBL] [Abstract][Full Text] [Related]
18. Modulation of antitumor alkylating agents (AA). Teicher BA; Frei E Cancer Treat Res; 1991; 57():261-95. PubMed ID: 1686721 [No Abstract] [Full Text] [Related]